News

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPs PD-L1 ISAC directly activates and reprograms PD-L1-expressing myeloid cells in the TME to drive complete responses ...
Legit.ng on MSN5d
See more as Uber, others get new rival as another ride hailing company launches in Lagos
Good news for ride-hailing drivers as a new company enters the market, offering better pay and zero commission after a fixed ...